Mass General Brigham · 5 hours ago
Post-Doctoral Research Fellow - Gene Editing Therapy
Mass General Brigham is a not-for-profit organization focused on patient care, research, teaching, and community service. They are seeking a Post-Doctoral Research Fellow to work on gene editing therapy for genetic hearing loss, with responsibilities including the development of new technologies and conducting IND-enabling studies to initiate clinical trials.
HealthcareHealth CareHome Health CareMedical
Responsibilities
Work on gene and editing therapy for genetic hearing loss and advancing findings toward clinical applications
Develop new technologies (e.g. RNA editing, epigenetic modifications, shRNA) for different forms of genetic hearing loss
Conduct multiple IND-enabling studies for gene and editing therapies with the goals to initiate clinical trials in 3 years
Employ state-of-the-art technologies, including in vitro adult cochlea explant culture, reprogramming, scRNAseq, inner ear organoids, genome editing, gene therapy, viral and non-viral delivery, and physiological function analysis
Collaborate with the industry, work with CROs, and interact with the FDA to bring work towards the clinic
Advance basic research to translational applications, including human studies
Qualification
Required
Ph.D., M.D./Ph.D., or M.D
Strong background in genetic hearing loss
In vivo animal inner ear study experience
AAV-mediated gene therapy and editing technology experience
Strong track record of scientific publications
Company
Mass General Brigham
Mass General Brigham specializes in providing medical treatments and health diagnostics services.
H1B Sponsorship
Mass General Brigham has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (77)
2024 (61)
2023 (93)
2022 (70)
2021 (80)
2020 (29)
Funding
Current Stage
Late StageLeadership Team
Recent News
2026-02-12
Medical Xpress - latest medical and health news stories
2026-02-11
Medical Xpress - latest medical and health news stories
2026-02-11
Company data provided by crunchbase